# Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on Metformin

> **NCT02033876** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 24 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Ursodiol

## Key facts

- **NCT ID:** NCT02033876
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2017-01
- **Final completion:** 2017-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02033876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02033876, "Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on Metformin". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02033876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*